ALZN Earnings Alzamend Neuro, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–16 of 16
| Q3 2026 | 2026-01-31 | -1.89 | 2026-03-11 | 10-Q |
| Q2 2026 | 2025-10-31 | -1.33 | 2025-12-09 | 10-Q |
| Q1 2026 | 2025-07-31 | -1.28 | 2025-09-10 | 10-Q |
| FY 2025 | 2025-04-30 | -11.32 | 2025-07-22 | 10-K |
| Q3 2026 | 2025-01-31 | -9.54 | 2026-03-11 | 10-Q |
| Q2 2026 | 2024-10-31 | -9.98 | 2025-12-09 | 10-Q |
| Q1 2026 | 2024-07-31 | -11.42 | 2025-09-10 | 10-Q |
| FY 2025 | 2024-04-30 | -132.33 | 2025-07-22 | 10-K |
| Q3 2024 | 2024-01-31 | -13.52 | 2025-03-10 | 10-Q |
| Q2 2024 | 2023-10-31 | -9.80 | 2024-12-11 | 10-Q |
| Q1 2024 | 2023-07-31 | -5.38 | 2024-09-11 | 10-Q |
| FY 2024 | 2023-04-30 | -22.89 | 2024-07-30 | 10-K |
| Q3 2024 | 2023-01-31 | -1.78 | 2024-03-25 | 10-Q |
| Q2 2024 | 2022-10-31 | -0.95 | 2023-12-15 | 10-Q |
| Q1 2024 | 2022-07-31 | -0.03 | 2023-09-13 | 10-Q |
| FY 2023 | 2022-04-30 | -0.14 | 2023-07-27 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.